Provided by Tiger Trade Technology Pte. Ltd.

WAVE Life Sciences

6.62
+0.25504.01%
Pre-market: 6.940.3207+4.84%05:16 EDT
Volume:6.28M
Turnover:40.94M
Market Cap:1.25B
PE:-5.46
High:6.76
Open:6.48
Low:6.27
Close:6.37
52wk High:21.73
52wk Low:5.02
Shares:188.25M
Float Shares:157.87M
Volume Ratio:0.43
T/O Rate:3.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2118
EPS(LYR):-1.2118
ROE:-54.97%
ROA:-27.18%
PB:2.40
PE(LYR):-5.46

Loading ...

Stock Track | WAVE Life Sciences Plummets 5.03% Intraday Following Analyst Ratings Release

Stock Track
·
Feb 27

Analysts Offer Insights on Healthcare Companies: Teleflex (TFX), Progyny (PGNY) and Wave Life Sciences (WVE)

TIPRANKS
·
Feb 27

Stock Track | WAVE Life Sciences Soars 5.06% Intraday on Q4 Revenue Beat and Promising Pipeline Updates

Stock Track
·
Feb 27

WAVE Life Sciences Ltd reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Feb 26

Wave Life Sciences Q4 revenue beats analyst expectations

Reuters
·
Feb 26

Earnings Flash (WVE) Wave Life Sciences Posts Q4 Loss $0.30 a Share, vs. FactSet Est of $0.26 Loss

MT Newswires Live
·
Feb 26

WAVE Life Sciences Q4 2025 EPS $(0.30) Misses $(0.27) Estimate, Sales $17.244M Beat $16.547M Estimate

Benzinga
·
Feb 26

Wave (WVE) Q4 revenue USD 17.2 million (-79.4%)

Reuters
·
Feb 26

Wave Life Sciences Q4 Net Income USD -53.179 Million VS. Ibes Estimate USD -45.9 Million

THOMSON REUTERS
·
Feb 26

Wave Life Sciences Q4 Pretax Profit USD -53.179 Million VS. Ibes Estimate USD -45.7 Million

THOMSON REUTERS
·
Feb 26

Wave Life Sciences Q4 EPS USD -0.3

THOMSON REUTERS
·
Feb 26

Wave Life Sciences Ltd: Well Capitalized With Cash and Cash Equivalents of $602.1 Mln as of December 31, 2025 and Expected Cash Runway Into 3Q 2028

THOMSON REUTERS
·
Feb 26

Wave Life Sciences CEO Paul Bolno to Join Oppenheimer Healthcare Life Sciences Conference Fireside Chat

Reuters
·
Feb 23

Wave Life Sciences Ltd. Schedules Webcast to Review Fourth-Quarter and Full-Year Financial Results

Reuters
·
Feb 19

Latest Ratings from Top Wall Street Analysts: Microsoft Downgraded, Snap Upgraded

Deep News
·
Feb 06

Wave Life Sciences Is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
Feb 05

Wave Life Sciences initiated with a Buy at BofA

TIPRANKS
·
Feb 05

Analysts Have Conflicting Sentiments on These Healthcare Companies: Wave Life Sciences (WVE) and Eli Lilly & Co (LLY)

TIPRANKS
·
Feb 05

Wave Life Sciences Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Feb 03

Wave Life Sciences Ltd : Canaccord Genuity Raises Target Price to $43 From $40

THOMSON REUTERS
·
Feb 03